BriaCell Therapeutics Corp. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
West Vancouver, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
31 July
BriaCell Therapeutics Corp. has filed 323 SEC EDGAR filings since 20 Jun 2014

SEC filing history

Showing 126-150 of 323 matching filings.

Per page
25
Current page
6
10-Q File 001-40101

10-Q filing

Filing date
14 Dec 2023
Reporting date
31 Oct 2023
Next action
Verify source filing
10-K File 001-40101

10-K filing

Filing date
25 Oct 2023
Reporting date
31 Jul 2023
Next action
Verify source filing
DEF 14A File 001-40101

DEF 14A filing

Filing date
26 Jul 2023
Reporting date
26 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40101

PRE 14A filing

Filing date
30 Jun 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40101

10-Q filing

Filing date
14 Jun 2023
Reporting date
30 Apr 2023
Next action
Verify source filing
EFFECT File 333-234292

EFFECT filing

Filing date
28 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-234292

POS AM filing

Filing date
20 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
16 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .